Skip to content
Menu

B. Riley Securities Initiates Coverage On Praxis Precision Medicine with Buy Rating, Announces Price Target of $713

Benzinga Newsdesk 6 hours ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

B. Riley Securities analyst Madison El-Saadi initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $713.

B. Riley Securities analyst Madison El-Saadi initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $713.

Read at benzinga.com